Monopar Therapeutics
MNPR
#9311
Rank
$15.98 M
Marketcap
$4.54
Share price
0.89%
Change (1 day)
53.38%
Change (1 year)

Monopar Therapeutics (MNPR) - Cash on Hand

Cash on Hand as of June 2024 : $7.11 M

According to Monopar Therapeutics's latest financial reports the company has $7.11 M in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

Monopar Therapeutics - Cash on Hand chart (from 2017 to 2024)

Cash on Hand by year

Year Cash on Hand Change
2022-12-31$13.11 M-35.38%
2021-12-31$20.3 M21.31%
2020-12-31$16.73 M26.66%
2019-12-31$13.21 M91.71%
2018-12-31$6.89 M-23.26%
2017-12-31$8.98 M333.36%
2016-12-31$2.07 M

Cash on Hand for similar companies or competitors

Company Cash on Hand differencediff. Country
$0.28 B 3,923.25%๐Ÿ‡บ๐Ÿ‡ธ USA